Brawn Biotech has informed that the Board of Directors of the Company at its meeting held on May 29, 2017, has recommended a final dividend of Rs 1.5 per equity share of face value of Rs 10 each for the year ended March 31, 2017 subject to approval of shareholders in the Annual General Meeting of the Company.
The above information is a part of company’s filings submitted to BSE.